Mechanical apparatus and method for dilating and delivering a therapeutic agent to a site of treatment

• US 7,488,313 B2
• Filed: 11/29/2001
• Issued: 02/10/2009
• Est. Priority Date: 11/29/2001
• Status: Active Grant

• Current Assignee: Boston Scientific Scimed (Boston Scientific Corporation)
• Original Assignee: Boston Scientific Scimed (Boston Scientific Corporation)
• Inventors: Segal, Jerome, Scott, Neal
• Primary Examiner(s): Lucchesi; Nicholas D
• Assistant Examiner(s): Stigell; Theodore J
• Application Number:
  US09/997,855
• Publication Number:
  US 20030100886A1
• Time in Patent Office: 2,630 Days
• Field of Search: 604/20, 604500-501, 604104-109, 604113-114, 604/271, 604507-510, 606190-194, 606/196, 606/198, 606/200, 600372-375, 600/377, 600/381, 607/115, 607/116, 607119-121
• US Class Current: 604/509
• CPC Class Codes: A61M 2025/0004 having two or more concentrically arranged tubes for forming a concentric catheter system
• CPC Class Codes: A61M 2025/0008 having visible markings on its surface, i.e. visible to the naked eye, for any purpose, e.g. insertion depth markers, rotational markers or identification of type
• CPC Class Codes: A61M 2025/0175 having telescopic features, interengaging nestable members movable in relations to one another
• CPC Class Codes: A61M 2025/0183 Rapid exchange or monorail catheters
• CPC Class Codes: A61M 2025/105 having a balloon suitable for drug delivery, e.g. by using holes for delivery, drug coating or membranes
• CPC Class Codes: A61M 29/02 Dilators made of swellable material balloon catheters for angioplasty A61M25/104
• CPC Class Codes: A61N 1/306 Arrangements where at least part of the apparatus is introduced into the body
• CPC Class Codes: A61P 35/00 Antineoplastic agents
• CPC Class Codes: A61P 37/02 Immunomodulators
• CPC Class Codes: A61P 43/00 Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
• CPC Class Codes: A61P 9/00 Drugs for disorders of the cardiovascular system

Abstract

A mechanical dilatation and medicament delivery device for enlarging a flow passage of a vessel by dilating and delivering a therapeutic agent or medicament to an obstruction in the vessel. The present invention comprises a substantially cylindrically shaped expansion member and includes a means engaged to the expansion member for altering the distance between the proximal end and the distal end of the expansion member thereby transforming the expansion member between a diametrically contracted configuration to diametrically expanded configuration. A therapeutic agent or medicament is coated on either the expansion member, or incorporated into a substrate coated on the expansion member.

The present method comprises the steps of advancing the coated expansion member to the obstruction in a vessel and applying opposed forces on said expansion member in an axial direction to move the expansion member to an expanded configuration wherein the expansion member dilates the obstruction and the expansion member either passively or actively delivers a therapeutic agent or medicament to the obstruction.

Claims

1. A method for dilating and delivering a medicament to an obstruction in a body passageway which comprises the steps of:

advancing a mechanical dilatation catheter to a predetermined site within a body passageway, said catheter having a cylindrically shaped expansion member coated with a medicament and an iontophoretic transport means, said cylindrically shaped expansion member being moveable between a first contracted configuration wherein said member is defined by a first dimension extending in a radial direction, and a second expanded configuration wherein said expansion member is defined by a second dimension extending in said radial direction;

applying a force on said cylindrically shaped expansion member in an axial direction to move said expansion member between said first contracted configuration to said second expanded configuration wherein said obstruction is dilated;

operating said iontophoretic means to deliver said medicament into said obstruction or body passageway;

further comprising, prior to advancing the catheter, the step of applying electrical energy to said expansion member to cause said medicament to electrically bond to said expansion member.

2. A method as recited in claim 1 wherein said expansion member comprises a first plurality of flexible elongate elements helically wound in a first direction of rotation and a second plurality of flexible elongate elements helically wound in a second direction of rotation to form a braid.

3. A method as recited in claim 1 wherein the expansion member is coated with a medicament comprising an anticoagulant.

4. A method as recited in claim 1 wherein the expansion member is coated with a medicament selected from the group consisting of D-Phe-Pro-Arg chloromethyl ketone, an RGD peptide-containing compound, heparin, an antithrombin compound, a platelet receptor antagonist, an anti-thrombin antibody, an anti-platelet receptor antibody, hirudin, hirulog, phe-pro-arg-chloromethyketone (Ppack), Factor VIIa, Factor Xa, aspirin, clopridogrel, ticlopidine, a prostaglandin inhibitor, a platelet inhibitor a and a tick anti-platelet peptide, and combinations thereof.

5. A method as recited in claim 1 wherein the expansion member is coated with a medicament comprising a promoter of vascular cell growth.

6. A method as recited in claim 1 wherein the expansion member is coated with a medicament selected from the group consisting of a growth factor stimulator, a growth factor receptor agonist, a transcriptional activator, and a translational promoter, and combinations thereof.

7. A method as recited in claim 1 wherein the expansion member is coated with a medicament comprising an inhibitor of vascular cell growth.

8. A method as recited in claim 1 wherein the expansion member is coated with a medicament selected from the group consisting of a growth factor inhibitor, a growth factor receptor antagonist, a transcriptional repressor, a translational repressor, an antisense DNA, an antisense RNA, a replication inhibitor, an inhibitory antibody, an antibody directed against growth factors, a bifunctional molecule consisting of a growth factor and a cytotoxin, and a bifunctional molecule consisting of an antibody and a cytotoxin, double stranded DNA, single stranded DNA, single stranded RNA and a double stranded RNA and combination thereof.

9. A method as recited in claim 1 wherein the expansion member is coated with a medicament comprising a cholesterol-lowering agent.

10. A method as recited in claim 1 wherein the expansion member is coated with a medicament comprising a vasodilating agent.

11. A method as recited in claim 1 wherein the expansion member is coated with a medicament comprising an agent that interferes with endogenous vasoactive mechanisms.

12. A method as recited in claim 1 wherein the expansion member is coated with a medicament selected from the group consisting of estrogen, testosterone, steroid hormones, cortisol, dexamethasone, corticosteroids, thyroid hormones, thyroid hormones analogs, thyroid hormones antagonist, adrenocorticotrophic hormone, thyroid stimulating hormone, thyroid releasing factor, thyroid releasing factor analogs, thyroid releasing factor antagonists and combinations thereof

13. A method as recited in claim 1 wherein the expansion member is coated with a medicament comprising a smooth muscle inhibitor.

14. A method as recited in claim 1 wherein the expansion member is coated with a medicament comprising an agent that modulates intracellular calcium binding proteins.

15. A method as recited in claim 1 wherein the expansion member is coated with a medicament comprising a receptor blocker for contractile agonists.

16. A method as recited in claim 1 wherein the expansion member is coated with a medicament selected from the group consisting of an inhibitor of the sodium/hydrogen antiporter, a protease inhibitor, a nitrovasodilator, phosphodiesterase inhibitor, a phenothiazine, a growth factor receptor agonist, an anti-mitotic agent, an immunosuppressive agent, and a protein kinase inhibitor, and combinations thereof

17. A method as recited in claim 1 wherein the expansion member is coated with a medicament comprises a compound that inhibits cellular proliferation.

18. A method as recited in claim 1 wherein the expansion member is coated with a medicament selected from the group consisting of Paclitaxel, Rapamycin, Sirolimus, Actinomycin D, Methotrexate, Doxorubicin, cyclophosphamide, and 5-fluorouracil, and combinations thereof.

19. A method as recited in claim 1 which further comprises the step of allowing said expansion member to be in said second expanded configuration for an indeterminate time period as necessary to delivery the medicament to the passageway.

20. A method as recited in claim 1 which further comprises the step of varying the electric current with time to provide a square waveform that controls the rate of iontophoretic of said medicament.

21. A method as recited in claim 1 wherein the passageway is a blood vessel.

22. A method as recited in claim 1 further comprising the step operating the expandable member to dilate the passageway.

23. A method as recited in claim 1 wherein the expansion member is coated with a combination of one or more medicaments and one or more polymers used to bond said medicaments to said expansion member.

24. A method as recited in claim 1 further comprising the step of providing the cylindrically shaped expansion member in the form of an expandable mesh.

25. A method as recited in claim 1 further comprising the step of providing the cylindrically shaped expansion member having an inner flow passage permitting fluid flow through the expansion member.

26. A method as recited in claim 1 further comprising operating said iontophoretic means to supply a flow of electrical current to the cylindrically shaped expansion member.

27. A method as recited in claim 1 which further comprises the step of positioning a guidewire in the body passageway, and wherein said advancing step is accomplished by threading said catheter over said guidewire.

28. A method as recited in claim 1 which further comprises the step of allowing said expansion member to be in said second expanded configuration for a predetermined period of time after the dilatation step to further expose said obstruction to the medicament.

29. A method as recited in claim 1 which further comprises the step of varying the electric current with time to provide a waveform that controls the rate of iontophorectic transport of said medicament.